Search results
Results From The WOW.Com Content Network
Optic nerve damage could cause or contribute to vision loss (including retinitis pigmentosa). ... If you want to take Cialis at night, you may have to stop eating grapefruit in the morning ...
Here’s how to make the most of finasteride to stop hair loss and boost hair growth: Don’t miss a daily dose. The treatment works best when you take a 1-milligram dose of finasteride daily .
Unlike regular finasteride side effects, the adverse reactions associated with post-finasteride syndrome can continue after someone stops taking it. Some men with PFS report symptoms that last for ...
This is also the case for Tamsulosin and it may be assumed that the others alpha-1 blockers work in a similar manner, since Tamsulosin is an alpha-1-a blocker and Prazosin is an alpha-1 blocker. [30] The risk for floppy iris syndrome during cataract surgery is elevated when the patient is using an alpha-1 blocker.
Intraoperative floppy iris syndrome (IFIS) is a complication that may occur during cataract extraction in certain patients. This syndrome is characterized by a flaccid iris which billows in response to ordinary intraocular fluid currents, a propensity for this floppy iris to prolapse towards the area of cataract extraction during surgery, and progressive intraoperative pupil constriction ...
This is a list of 5α-reductase inhibitors (5α-RIs), drugs which inhibit one or more isoforms of the enzyme 5α-reductase.This enzyme is responsible for the conversion of the androgen hormone testosterone into the more potent dihydrotestosterone (DHT) and is essential for the production of neurosteroids like allopregnanolone, tetrahydrodeoxycorticosterone (THDOC), and 3α-androstanediol from ...
Finasteride belongs to a group of medications called 5-alpha reductase inhibitors. These medications prevent the conversion of testosterone to dihydrotestosterone, which can prevent further hair ...
Finasteride was the first 5-ARI to be introduced for medical use. [43] It was marketed for the treatment of BPH in 1992 and was subsequently approved for the treatment of pattern hair loss in 1997. [43] Epristeride was the second 5-ARI to be introduced and was marketed for the treatment of BPH in China in 2000. [14]